Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Development and Reliability and Validity Testing of a Health Literacy Assessment Scale for Nursing Assistants

29 de septiembre de 2026 actualizado por: Zhang Xin, The First Affiliated Hospital of Air Force Medical University

The goal of this observational study is to develop and evaluate a health literacy assessment scale for caregivers (nursing assistants) working in medical institutions, based on their job characteristics and caregiving needs. The main questions it aims to answer are:

Can the newly developed scale validly and reliably measure health literacy among caregivers in healthcare settings?

What is the current level of health literacy among caregivers, and which factors are associated with it?

Caregivers working in medical institutions (aged 18-65, with at least 3 months of caregiving experience) will complete survey questionnaires about their health literacy, health behaviors, and job characteristics. A subset will repeat the survey 14 days later to assess test-retest reliability.

Descripción general del estudio

Estado

Inscripción por invitación

Condiciones

Intervención / Tratamiento

Descripción detallada

This is a non-interventional, methodological, mixed-methods study designed to develop and psychometrically validate a health literacy assessment scale for caregivers (nursing assistants) working in medical institutions. The study is guided by the Timing Theory and integrates qualitative semi-structured interviews, two rounds of Delphi expert consultation, and a quantitative multicenter questionnaire survey.

**Study Design and Theoretical Framework** The study adopts a mixed-methods design. Based on the Timing Theory and the concept of health literacy, an initial item pool will be generated through literature review and semi-structured interviews with caregivers. The item pool will then be refined through two rounds of Delphi expert consultation. Subsequently, a pilot survey and a large-sample multicenter survey will be conducted to evaluate the psychometric properties (validity and reliability) of the scale.

**Study Phases**

  • **Phase 1 - Item pool generation and first-round Delphi:** Literature review, theoretical framework construction, and semi-structured interviews with 10-15 caregivers (each interview lasting 20-30 minutes) will be conducted to form the initial item pool, followed by the first round of Delphi expert consultation.
  • **Phase 2 - Second-round Delphi and pilot survey:** The second round of Delphi expert consultation will be completed, and a small-sample pilot survey will be conducted to optimize the scale, resulting in the formal version of the caregiver health literacy assessment scale.
  • **Phase 3 - Large-sample multicenter survey:** A multicenter large-sample questionnaire survey will be conducted at tertiary general hospitals and related healthcare institutions. Data collection, entry, and processing will be completed, and a subsample will undergo a retest survey 14 days after the initial survey to assess test-retest reliability.
  • **Phase 4 - Psychometric evaluation:** Item analysis, validity testing, and reliability testing will be performed using SPSS 27.0 and AMOS 28.0 to determine the final version of the scale.
  • **Phase 5 - Manuscript preparation:** Research findings will be summarized and manuscripts will be prepared for submission.

**Sample Size** According to scale development requirements, the item-to-sample ratio should be 1:5 to 1:10. Exploratory factor analysis (EFA) requires at least 150 participants, and confirmatory factor analysis (CFA) requires at least 200 participants. Considering a potential 10% invalid response rate, the target sample size is set at N ≥ 300. The study plans to enroll approximately 300-400 caregivers across multiple centers.

**Quality Control and Data Management**

  • Investigators, interviewers, and data managers will receive unified training to standardize procedures and scripts.
  • One-on-one guidance will be provided during questionnaire completion; completeness and logical consistency will be checked on-site, and missing items will be supplemented promptly.
  • Double data entry and logical verification will be performed; invalid questionnaires will be excluded according to predefined criteria (key items missing ≥10%, regular or monotonous answering patterns, excessively short completion time, logical contradictions, or incomplete data).
  • Expert qualifications will be strictly screened; unified Delphi consultation forms and standardized collection, organization, and feedback procedures will be used.
  • Data will be anonymized using questionnaire codes, encrypted for storage, and retained for at least 5 years. Only members of the research team will have access to the data.

**Statistical Analysis Plan** Data will be analyzed using SPSS 27.0 and AMOS 28.0. Continuous variables will be presented as mean ± standard deviation or median (interquartile range); categorical variables will be presented as frequencies and percentages.

  • **Item analysis:** critical ratio method, item-total correlation, and homogeneity test.
  • **Validity:** construct validity will be evaluated through EFA and CFA; content validity will be assessed using the content validity index (CVI); convergent validity will be evaluated using average variance extracted (AVE); discriminant validity will be assessed using composite reliability (CR).
  • **Reliability:** internal consistency will be evaluated using Cronbach's α coefficient; split-half reliability will be calculated; test-retest reliability will be assessed using the intraclass correlation coefficient (ICC).

All statistical tests will be two-tailed, with a significance level of α = 0.05 (P < 0.05 considered statistically significant).

**Missing Data** Questionnaires with key items missing ≥10% will be excluded. For included questionnaires, missing data will be documented and handled according to predefined rules; variables reported as missing, unavailable, or inconsistent will be recorded, and appropriate statistical handling (e.g., pairwise deletion or multiple imputation where justified) will be applied and reported transparently.

**Ethical Considerations** The study will be conducted in accordance with the Declaration of Helsinki and has been approved by the Ethics Committee of the First Affiliated Hospital of the Air Force Medical University (Xijing Hospital). The study is non-interventional, involving only questionnaires, interviews, and expert consultation; no drugs, invasive procedures, or biological samples are involved, and there is no anticipated risk of adverse events. Informed consent is exempted under the ethics approval, and participant privacy and data confidentiality will be protected throughout the study.

Tipo de estudio

De observación

Inscripción (Estimado)

1000

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • Shanxi
      • Xi’an, Shanxi, Porcelana, 710032
        • The First Affiliated Hospital of Air Force Medical University

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años a 65 años (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

Sí

Géneros elegibles para el estudio

Todos

Método de muestreo

Muestra no probabilística

Población de estudio

Nursing assistants (Caregivers) aged 18-65 years who have been working in medical institutions (including tertiary general hospitals and related healthcare facilities) for at least 3 months, with basic communication skills and the ability to understand the questionnaire. Approximately 300-400 eligible caregivers will be recruited across multiple centers. Interns, temporary support staff, non-regular in-service caregivers, individuals with severe hearing, speech, or cognitive impairment, those with frequent leave or imminent departure, and those who refuse or are unable to complete the questionnaire are excluded.

Descripción

Inclusion Criteria:

Aged 18 to 65 years.

  • Working as a caregiver (nursing assistant) in a medical institution (including tertiary general hospitals and related healthcare facilities) for at least 3 months.
  • Has basic communication skills and the ability to understand the questionnaire.
  • No recent job changes, and able to cooperate with the survey and the 14-day retest.
  • Informed of the study and willing to participate.

Exclusion Criteria:

  • Interns, temporary support staff, or non-regular in-service caregivers.
  • Severe hearing, speech, or cognitive impairment that prevents communication.
  • Frequent leave in the past month or imminent departure from the position.
  • Refusal or inability to complete the questionnaire.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Modelos observacionales: OTHER
  • Perspectivas temporales: CROSS_SECTIONAL

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Structural validity of the Health Literacy Assessment Scale for Nursing Assistants
Periodo de tiempo: At completion of data analysis (approximately 3 months after the end of the large-sample survey).

The structural validity of the newly developed Health Literacy Assessment Scale for Nursing Assistants will be evaluated using exploratory factor analysis (EFA) and confirmatory factor analysis (CFA), based on factor loadings and model fit indices.

At completion of data analysis (approximately 3 months after the end of the large-sample survey).
Content validity of the Health Literacy Assessment Scale for Nursing Assistants
Periodo de tiempo: At completion of data analysis (approximately 3 months after the end of the large-sample survey).

The content validity of the newly developed Health Literacy Assessment Scale for Nursing Assistants will be evaluated using the Content Validity Index (CVI).

At completion of data analysis (approximately 3 months after the end of the large-sample survey).
Convergent validity of the Health Literacy Assessment Scale for Nursing Assistants
Periodo de tiempo: At completion of data analysis (approximately 3 months after the end of the large-sample survey).

The convergent validity of the newly developedHealth Literacy Assessment Scale for Nursing Assistants will be evaluated using Average Variance Extracted (AVE).

At completion of data analysis (approximately 3 months after the end of the large-sample survey).
Internal consistency reliability of the Health Literacy Assessment Scale for Nursing Assistants
Periodo de tiempo: At completion of data analysis (approximately 3 months after the end of the large-sample survey).

The internal consistency reliability of the newly developed Health Literacy Assessment Scale for Nursing Assistants will be evaluated using Cronbach's α coefficient, Composite Reliability (CR), and split-half reliability.

At completion of data analysis (approximately 3 months after the end of the large-sample survey).
Test-retest reliability of the Health Literacy Assessment Scale for Nursing Assistants
Periodo de tiempo: 14 days after the initial survey.

The test-retest reliability of the newly developed Health Literacy Assessment Scale for Nursing Assistants will be evaluated using the Intraclass Correlation Coefficient (ICC) at a 14-day interval.

14 days after the initial survey.

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Publicaciones Generales

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

22 de junio de 2026

Finalización primaria (Actual)

25 de septiembre de 2026

Finalización del estudio (Estimado)

30 de diciembre de 2026

Fechas de registro del estudio

Enviado por primera vez

14 de septiembre de 2026

Primero enviado que cumplió con los criterios de control de calidad

29 de septiembre de 2026

Publicado por primera vez (Actual)

2 de octubre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

2 de octubre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

29 de septiembre de 2026

Última verificación

1 de septiembre de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • KY20262267-C-1

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Descripción del plan IPD

  • The protocol states: "Data will be encrypted and stored for at least 5 years, used for subsequent research analysis, without disclosing personal information."
  • "Only the research team will have access to the data" (questionnaire-coded anonymization, encrypted storage).
  • Participants are caregivers, and the data includes sensitive personal information (name, age, education, work tenure, health behaviors, contact details).
  • The document does not mention any plan to share individual participant data (IPD) with external researchers.

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .